Cameron Avrigean

White Paper | ACOG – Screening for Chromosomal Abnormalities

Home » Archives for Cameron Avrigean » Page 2 Screening for Fetal Chromosomal Abnormalities Prenatal testing for chromosomal abnormalities is designed to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. A wide variety of prenatal screening and diagnostic tests are available; each offers varying levels of information …

White Paper | ACOG – Screening for Chromosomal Abnormalities Read More »

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS)

Home » Archives for Cameron Avrigean » Page 2 Considerations When Ordering Non-invasive Prenatal Screening (NIPS) NIPS generally relies on blood testing from the mother to reveal information from circulating cell-free DNA (cfDNA) from the placenta, which can be identified in the maternal plasma from five weeks after conception. CfDNA is released into the blood …

White Paper | Considerations When Ordering Non-invasive Prenatal Screening (NIPS) Read More »

SignatureDx – What We Do

Home » Archives for Cameron Avrigean » Page 2 SignatureDx Resources – What We Do One Pager Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation. Download PDF